Evaluation of Salivary Biomarkers in Individuals With Bruxism
BRUXSAL
Salivary Biomarkers and Perceived Stress in Individuals With Bruxism: A Case-Control Study
1 other identifier
observational
56
1 country
1
Brief Summary
The goal of this observational study is to evaluate salivary biomarkers and perceived stress in adults with bruxism compared with healthy individuals. The study aims to determine whether salivary cortisol, immunoglobulin A (IgA), free kappa light chain (FLC-κ), free lambda light chain (FLC-λ), total free light chains, and perceived stress levels differ between individuals with bruxism and healthy controls. The main questions it aims to answer are:
- Do salivary cortisol, IgA, FLC-κ, FLC-λ, and total free light chain levels differ between individuals with bruxism and healthy controls?
- Is perceived stress associated with changes in salivary biomarkers in individuals with bruxism? Researchers will compare participants with bruxism and healthy control participants to evaluate differences in salivary biomarker levels and perceived stress. Participants will:
- undergo a clinical examination for the diagnosis of bruxism or confirmation of healthy status;
- complete the Perceived Stress Scale (PSS-14) questionnaire;
- provide an unstimulated saliva sample for laboratory analysis of cortisol, IgA, free kappa light chain, free lambda light chain, and total free light chains.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2026
CompletedFirst Submitted
Initial submission to the registry
July 9, 2026
CompletedFirst Posted
Study publicly available on registry
July 14, 2026
CompletedJuly 14, 2026
July 1, 2026
12 months
July 9, 2026
July 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perceived stress score (PSS-14 score)
Comparison of PSS-14 scores between individuals with bruxism and non-bruxism controls.
Baseline
Secondary Outcomes (1)
Salivary biomarker levels (cortisol, IgA, FLC-κ, FLC-λ, and total FLC)
Baseline
Study Arms (2)
Bruxism
Adults diagnosed with bruxism based on clinical diagnostic criteria.
Healthy Controls
Age- and sex-matched healthy adults without signs or symptoms of bruxism.
Eligibility Criteria
The study population consisted of adults with clinically diagnosed bruxism and age- and sex-matched healthy control participants recruited from the Faculty of Dentistry. All participants underwent clinical examination, completed the Perceived Stress Scale (PSS-14), and provided unstimulated saliva samples for biomarker analysis.
You may qualify if:
- Adults aged 25 to 50 years.
- Systemically healthy individuals.
- Presence of no more than four-unit fixed partial dentures.
- Absence of clinical signs of oral inflammation.
- Good oral hygiene.
- Individuals diagnosed with bruxism according to the study diagnostic criteria (bruxism group) or healthy volunteers without signs or symptoms of bruxism (control group).
- Ability and willingness to provide written informed consent.
You may not qualify if:
- Use of medications that may affect the nervous system or salivary gland function (e.g., benzodiazepines, antidepressants).
- Psychiatric disorders.
- Epilepsy.
- Diabetes mellitus or other pancreatic diseases.
- Current corticosteroid therapy.
- Cushing syndrome or Addison disease.
- Pregnancy.
- Current smoking.
- Alcohol or substance abuse.
- History of facial trauma.
- Rheumatic muscle or joint disorders.
- Degenerative joint disease.
- Migraine.
- Use of medications affecting sleep or motor activity.
- Recent history of occlusal splint therapy.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Giresun Universitylead
- Cumhuriyet Universitycollaborator
Study Sites (1)
Giresun University Faculty of Dentistry
Giresun, 28200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tugce Cevik Sonmez, DDS
Giresun University Faculty of Dentistry
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 9, 2026
First Posted
July 14, 2026
Study Start
May 4, 2025
Primary Completion
April 30, 2026
Study Completion
June 15, 2026
Last Updated
July 14, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share